Description of a new human breast cancer cell line, IIB-BR-G, established from a primary undifferentiated tumor
- PMID: 1661624
- DOI: 10.1007/BF01975204
Description of a new human breast cancer cell line, IIB-BR-G, established from a primary undifferentiated tumor
Abstract
The establishment of a new human breast cancer cell line (IIB-BR-G) was successful after a previous growth of the cells isolated from a breast primary tumor in a female nude mouse. The IIB-BR-G cell line and the primary tumor do not express estrogen or progesterone receptors. Vimentin and keratin expression were found in the cell line and in the nude mouse tumor. This cell line displays high morphological heterogeneity with atypical multinucleated megacells, and it is capable of anchorage-independent growth and tumor formation in nude mice. The cytogenetic analysis confirmed its human origin and revealed multiple marker chromosomes and extensive chromosomal alterations including rearrangements, gains, losses, isochromosomes, and double minutes (DMs).
Similar articles
-
Protein expression changes during human triple negative breast cancer cell line progression to lymph node metastasis in a xenografted model in nude mice.Cancer Biol Ther. 2012 Sep;13(11):1123-40. doi: 10.4161/cbt.21187. Epub 2012 Jul 24. Cancer Biol Ther. 2012. PMID: 22825326 Free PMC article.
-
The human breast cancer cell line IIB-BR-G has amplified c-myc and c-fos oncogenes in vitro and is spontaneously metastatic in vivo.Cell Mol Biol (Noisy-le-grand). 1998 May;44(3):493-504. Cell Mol Biol (Noisy-le-grand). 1998. PMID: 9620446
-
Establishment and characterization of a new cell line (VHB-1) derived from a primary breast carcinoma.J Cancer Res Clin Oncol. 1987;113(6):550-8. doi: 10.1007/BF00390864. J Cancer Res Clin Oncol. 1987. PMID: 2824520 Free PMC article.
-
Xenograft models of premalignant breast disease.J Mammary Gland Biol Neoplasia. 2000 Oct;5(4):379-91. doi: 10.1023/a:1009577811584. J Mammary Gland Biol Neoplasia. 2000. PMID: 14973383 Review.
-
HER2 as a prognostic factor in breast cancer.Oncology. 2001;61 Suppl 2:67-72. doi: 10.1159/000055404. Oncology. 2001. PMID: 11694790 Review.
Cited by
-
Cetuximab and IL-15 Promote NK and Dendritic Cell Activation In Vitro in Triple Negative Breast Cancer.Cells. 2020 Jun 28;9(7):1573. doi: 10.3390/cells9071573. Cells. 2020. PMID: 32605193 Free PMC article.
-
Avelumab, an IgG1 anti-PD-L1 Immune Checkpoint Inhibitor, Triggers NK Cell-Mediated Cytotoxicity and Cytokine Production Against Triple Negative Breast Cancer Cells.Front Immunol. 2018 Sep 20;9:2140. doi: 10.3389/fimmu.2018.02140. eCollection 2018. Front Immunol. 2018. PMID: 30294328 Free PMC article.
-
Functional properties of FC-2.15, a monoclonal antibody that mediates human complement cytotoxicity against breast cancer cells.Cancer Immunol Immunother. 1995 Jul;41(1):15-22. doi: 10.1007/BF01788955. Cancer Immunol Immunother. 1995. PMID: 7641216 Free PMC article.
-
Protein expression changes during human triple negative breast cancer cell line progression to lymph node metastasis in a xenografted model in nude mice.Cancer Biol Ther. 2012 Sep;13(11):1123-40. doi: 10.4161/cbt.21187. Epub 2012 Jul 24. Cancer Biol Ther. 2012. PMID: 22825326 Free PMC article.
-
Human macrophages and dendritic cells can equally present MART-1 antigen to CD8(+) T cells after phagocytosis of gamma-irradiated melanoma cells.PLoS One. 2012;7(7):e40311. doi: 10.1371/journal.pone.0040311. Epub 2012 Jul 2. PLoS One. 2012. PMID: 22768350 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Other Literature Sources
Medical
Research Materials